Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Liabilities from Discontinued Operations (2020 - 2021)

Agios Pharmaceuticals' Liabilities from Discontinued Operations history spans 2 years, with the latest figure at 34533000.0 for Q1 2021.

  • For Q1 2021, Liabilities from Discontinued Operations changed N/A year-over-year to 34533000.0; the TTM value through Mar 2021 reached 34533000.0, changed N/A, while the annual FY2020 figure was 38459000.0, N/A changed from the prior year.
  • Liabilities from Discontinued Operations reached 34533000.0 in Q1 2021 per AGIO's latest filing, down from 38459000.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 38459000.0 in Q4 2020 to a low of 34533000.0 in Q1 2021.